Int'l : +1(646) 832-2886 | query@kbvresearch.com
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV Research, The Global Spirometer Market size is expected to reach USD 1511.6 million by 2033, rising at a market growth of 7.9% CAGR during the forecast period.
Greater emphasis on respiratory health assessment and long-term pulmonary monitoring is increasing the use of spirometry across hospitals, clinics, diagnostic centers, and homecare environments. Healthcare providers are adopting portable and digital spirometers to support COPD diagnosis, asthma management, preventive screening, occupational assessment, and routine lung-function testing. Wireless connectivity, mobile applications, cloud-based reporting, and electronic health record integration are making respiratory data easier to capture and manage. Connected devices are also expanding spirometry beyond traditional pulmonary laboratories into outpatient and remote-care settings.
The Volume Measurement segment acquired the highest revenue share in the Global Spirometer Market by Type in 2025, thereby, achieving a market value of USD 1057.9 million by 2033. Volume measurement systems are extensively used for comprehensive pulmonary function testing across hospitals, specialty clinics, diagnostic centers, and respiratory laboratories. These devices enable detailed evaluation of lung volumes, airflow patterns, and respiratory performance across conditions such as COPD, asthma, and restrictive lung disorders. Their clinical relevance makes them important for diagnosis, disease monitoring, and treatment assessment. Continued use in structured pulmonary testing environments reinforces the segment's leading market position.
The Devices segment acquired the highest revenue share in the Global Spirometer Market by Product Type in 2025, thereby, achieving a market value of USD 838.8 million by 2033. Devices remain central to spirometry as healthcare providers continue adopting portable, handheld, and desktop systems for clinical and remote respiratory assessment. Product development is increasingly focused on compact design, measurement accuracy, ease of use, connectivity, and compatibility with digital healthcare platforms. Portable systems are also improving access to testing across primary care and decentralized settings. Continued demand for reliable pulmonary-function equipment supports the segment's dominant market position.
The Chronic Obstructive Pulmonary Disorder (COPD) segment acquired the highest revenue share in the Global Spirometer Market by Application in 2025, thereby, achieving a market value of USD 726.8 million by 2033. Spirometry plays an important role in detecting persistent airflow limitation, evaluating disease severity, tracking respiratory performance, and monitoring treatment outcomes among COPD patients. Increasing focus on earlier respiratory assessment is encouraging broader use of pulmonary-function testing across different levels of care. Digital tools and portable devices are also supporting more convenient monitoring of chronic respiratory conditions. These factors continue to strengthen the segment's market leadership.
The Hospitals segment acquired the highest revenue share in the Global Spirometer Market by End User in 2025, thereby, achieving a market value of USD 465.3 million by 2033. Hospitals maintain significant demand for spirometers due to large patient volumes, established pulmonary departments, comprehensive diagnostic infrastructure, and routine respiratory testing requirements. These facilities use spirometry for disease diagnosis, preoperative assessment, chronic respiratory management, and specialized pulmonary evaluation. Integration with digital records and broader pulmonary function systems is further improving clinical workflows. Continued availability of specialized respiratory services reinforces the segment's leading position.
Full Report: https://www.kbvresearch.com/spirometer-market/
The North America segment recorded the highest revenue share in the Global Spirometer Market by Region in 2025, thereby, achieving a market value of USD 565.1 million by 2033. The region benefits from established respiratory care infrastructure, strong adoption of pulmonary-function testing, access to advanced diagnostic technologies, and widespread specialized healthcare services. Hospitals and clinics are increasingly integrating portable, connected, and software-enabled spirometry into routine respiratory care. Growing use of digital health and remote monitoring is also extending testing beyond conventional clinical settings. These factors are expected to maintain North America's leading market position throughout the forecast period.
By Type
By Product Type
By Application
By End User
By Geography
Related Reports: